Brief: Dermapharm 9-Month Group Sales Up At EUR 670.2 Million

Dermapharm Holding SE

16/11/2021 06:34

Nov 16 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * MANAGEMENT BOARD INCREASES EBITDA FORECAST FOR FULL YEAR
2021
    * 9-MONTH GROUP SALES UP 16.1% TO € 670.2 MILLION
    * 9-MONTH ADJUSTED GROUP EBITDA INCREASED BY 63.9% TO €
227.8
MILLION
    * OUTLOOK 2021: NOW ANTICIPATING GROWTH IN GROUP SALES OF
15% TO
20% (PREVIOUSLY 24% TO 26%) AND GROUP EBITDA OF 50% TO 60%
(PREVIOUSLY: 45% TO 50%)

Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))